three-component coupling,17 MoritaÀBaylisÀHilmann
reaction,18 and silver-catalyzed oxidative cross-coupling
reaction.19 Also in all these latter cases various aminopyr-
idine derivatives were employed as starting materials.
Recently, Cronin reported an interesting five-step one-
pot procedure leading to imidazo-pyridine derivatives
that does not require R-amino functionalized starting
materials.20
Domino processes represent an inviting method for a
facile construction of the molecular architecture because
they represent an access to the formation of several new
bonds in a single manipulation. These processes are oper-
ationally simple and minimize the production of chemical
waste.21 From the perspective of green chemistry,22
domino processes under solvent-free conditions (SFC)
are fascinating since they involve the best reaction medium
with “no medium”.23
By exploiting our experience in the field of 1,2-diaza-
1,3-dienes (DDs) in the syntheses of several five- and
six-membered azaheterocycles,24 we have thought to plan
a more simple methodology for the assembly of IPs, IQs,
and IIQs based on their use. In the nitrogen-bridgehead
heterocycles construction (Scheme 1) two strategic discon-
nections of the imidazole core can be envisaged along the
N(1)ÀC(8a) and N(4)ÀC(3) bonds.
Figure 1. Drugs based on imidazo[1,2-a]pyridines.
On the other hand, IPs, IQs, and IIQs have been investi-
gated as biomarkers and photochemical sensors, since
they are important organic fluorophores.9 By virtue of
these relevant applications, efficient strategies for their
synthesis have been developed.10 In particular, the most
employed method for the synthesis of IPS involves the
use of 2-aminopyridines in the coupling reactions with
R-halocarbonyl compounds, and in the condensations
with aldehydes or isonitriles.11 Usually, these syntheses
require harsh conditions. Some other recent examples
include a water-mediated hydroamination,12 silver-cata-
lyzed cyclization,13 copper-catalyzed dehydrogenative
aminooxygenation,14 TBAI-catalyzed oxidative coupling,15
copper-catalyzed aromatic amination,16 copper-catalyzed
Scheme 1. Comparison between the Retrosynthetic Analysis to
Assemble IPs Proposed in This Work and the Most Commonly
Employed
(7) Iminov, R. T.; Tverdokhlebov, A. V.; Tolmachev, A. A.;
Volovenko, Y. M.; Kostyuk, A. N.; Chernega, A. N.; Rusanov, E, B.
Synthesis 2008, 1535–1540 and references cited therein.
(8) (a) Deady, L. W.; Rodemann, T.; Finlay, G. J.; Baguley, B.;
Denny, W. A. C. Anti-Cancer Drug Des. 2001, 15, 339–346. (b) Rhee, H.-
K.; So Lim, S. Y.; Jung, M.-J.; Kwon, Y.; Kim, M.-H.; Choo, H.-Y. P.
Bioorg. Med. Chem. 2009, 17, 7537–7541.
(9) (a) Hodgkiss, R. J.; Middleton, R. W.; Parrick, J.; Rami, H. K.;
Wardman, P.; Wilson, G. D. J. Med. Chem. 1992, 35, 1920–1936.
(b) Shao, N.; Pang, G. X.; Yan, C. X.; Shi, G. F.; Cheng, Y. J. Org.
Chem. 2011, 76, 7458–7465.
(10) Katrizky, A. R.; Xu, Y.-J.; Tu, H. J. Org. Chem. 2003, 68, 4935–
4937 and reference therein.
(11) For some example: (a) Gueiffier, A.; Mavel, S.; Lhassani, M.;
Elhakmaoui, A.; Snoeck, R.; Andrei, G.; Chavignon, O.; Teulade, J.-C.;
Witvrouw, M.; Balzarini, J.; De Clercq, E.; Chapat, J.-P. J. Med. Chem.
1998, 41, 5108–5112. (b) Groebke, K.; Weber, L.; Mehlin, F. Synlett
1998, 661–663. (c) Koubachi, J.; El Kazzouli, S.; Berteina,-Raboin, S.;
Mouaddib, A.; Guillaumet, G. J. Org. Chem. 2007, 72, 7650–7655.
(d) Herath, A.; Dahl, R.; Cosford, N. P. D. Org. Lett. 2010, 12, 412–415.
(e) Shukla, N. M.; Salunke, D. B.; Yoo, E.; Mutz, C. A.; Balakrishna, R.;
David, S. A. Bioorg. Med. Chem. 2012, 20, 5850–5863.
(12) Mohan, D. P.; Rao, S. N.; Adimurthy, S. J. Org. Chem. 2013, 78,
1266–1272.
(13) Chioua, M.; Soriano, E.; Infantes, L.; Jimeno, M. L.; Marco-
Contelles, J.; Samadi, A. Eur. J. Org. Chem. 2013, 35–39.
(14) Wang, H. G.; Wang, Y.; Liang, D. D.; Liu, L. Y.; Zhang, J. C.;
Zhu, Q. Angew. Chem., Int. Ed. 2011, 50, 5678–5681.
(15) Ma, L. J.; Wang, X. P.; Yu, W.; Han, B. Chem. Commun. 2011,
47, 11333–11135.
Thus, two subunits can be evidenced: a pyridine ring 2,
and an unusual zwitterion B bearing an electrophilic center
in R-position to the imine moiety, instead of the ordinary
nucleophilic site. Fortunately, DDs 1 constitute an umpo-
lung of the classical carbonyl reactivity,24a since these
neutral compounds enable nucleophilic additions at the
terminal carbon atom of the azo-ene system. Thus, the
initial conjugate 1,4-addition of the pyridine 2 to DD 1
(19) He, C.; Hao, I.; Xu, H.; Mo, Y.; Liu, H.; Han, J.; Lei, A. Chem.
Commun. 2012, 48, 11073–11075.
(20) Parenty, A. D. C.; Song, Y.-F.; Richmond, C. J.; Cronin, L. Org.
Lett. 2007, 9, 2253–2256.
(16) Yan, R. L.; Yan, H.; Ma, C.; Ren, Z. Y.; Gao, X. A.; Hang,
G. S.; Liang, Y. M. J. Org. Chem. 2012, 77, 2024–2028 and references
therein.
(17) (a) Chernyak, N.; Gevorgyan, V. Angew. Chem., Int. Ed. 2010,
49, 2743–2746. (b) Guchait, S. K.; Changude, A. L.; Priyadarshani, G.
J. Org. Chem. 2012, 77, 4438–4444.
(21) Reviews on domino reactions: (a) Tietze, L. F. Chem. Rev. 1996,
96, 115–136. (b) Pellissier, H. Tetrahedron 2006, 62, 2143–2173.
(c) Grondal, C.; Jeanty, M.; Enders, D. Nat. Chem. 2010, 2, 167–178.
(22) Anastas, P. T.; Warner, J. C. Green Chemistry: Theory and
Practice; Oxford: New York, 1998.
(23) (a) Martins, M. A. P.; Frizzo, C. P.; Moreira, N. D.; Buriol, L.;
Machado, P. Chem. Rev. 2009, 109, 4140–4182. (b) Tanaka, K. Solvent-
Free Organic Synthesis; Wiley-VCH: Weinheim, Germany, 2009.
(18) Nair, D. K.; Mobin, S. M.; Namboothiri, N. N. Org. Lett. 2012,
14, 4580–4583 and references therein.
B
Org. Lett., Vol. XX, No. XX, XXXX